Starkage Therapeutics
About:
Starkage Therapeutics is a biotechnology company that aims to delay and improve quality of life of patients with age-related diseases.
Website: https://starkagetx.com/
Twitter/X: starkagetx
Top Investors: Bpifrance
Description:
Starkage Therapeutics is a discovery-stage biotechnology company. They also provide treatment for idiopathic pulmonary fibrosis, neurodegenerative diseases, and metabolic dysfunction or hepatic fibroses.
Total Funding Amount:
3.2M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Lille, Nord-Pas-de-Calais, France
Founded Date:
2018-01-01
Contact Email:
contact(AT)starkagetx.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-05-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai